Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.
Rosenberg, S A
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. [electronic resource] - Nature medicine Mar 1998 - 321-7 p. digital
Publication Type: Clinical Trial; Journal Article
1078-8956
10.1038/nm0398-321 doi
Adult
Cancer Vaccines--therapeutic use
Drug Therapy, Combination
Evaluation Studies as Topic
Female
HLA-A2 Antigen--immunology
Humans
Immunization
Interleukin-2--therapeutic use
Lung Neoplasms--secondary
Melanoma--therapy
Membrane Glycoproteins--therapeutic use
Middle Aged
Neoplasm Metastasis
Oligopeptides--therapeutic use
Peptide Fragments--therapeutic use
gp100 Melanoma Antigen
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. [electronic resource] - Nature medicine Mar 1998 - 321-7 p. digital
Publication Type: Clinical Trial; Journal Article
1078-8956
10.1038/nm0398-321 doi
Adult
Cancer Vaccines--therapeutic use
Drug Therapy, Combination
Evaluation Studies as Topic
Female
HLA-A2 Antigen--immunology
Humans
Immunization
Interleukin-2--therapeutic use
Lung Neoplasms--secondary
Melanoma--therapy
Membrane Glycoproteins--therapeutic use
Middle Aged
Neoplasm Metastasis
Oligopeptides--therapeutic use
Peptide Fragments--therapeutic use
gp100 Melanoma Antigen